Bcl-2 overexpression in hepatic stellate cell line CFSC-2G, induces a pro-fibrotic state

J Gastroenterol Hepatol. 2010 Jul;25(7):1306-14. doi: 10.1111/j.1440-1746.2009.06175.x.

Abstract

Background and aim: Development of hepatic fibrosis is a complex process that involves oxidative stress (OS) and an altered balance between pro- and anti-apoptotic molecules. Since Bcl-2 overexpression preserves viability against OS, our objective was to address the effect of Bcl-2 overexpression in the hepatic stellate cells (HSC) cell-line CFSC-2G under acetaldehyde and H(2)O(2) challenge, and explore if it protects these cells against OS, induces replicative senescence and/or modify extracellular matrix (ECM) remodeling potential.

Methods: To induce Bcl-2 overexpression, HSC cell line CFSC-2G was transfected by lipofection technique. Green fluorescent protein-only CFSC-2G cells were used as a control. Cell survival after H(2)O(2) treatment and total protein oxidation were assessed. To determine cell cycle arrest, proliferation-rate, DNA synthesis and senescence were assessed. Matrix metalloproteinases (MMP), tissue-inhibitor of MMP (TIMP), transglutaminases (TG) and smooth muscle a-actin (alpha-SMA) were evaluated by western blot in response to acetaldehyde treatment as markers of ECM remodeling capacity in addition to transforming growth factor-beta (TGF-beta) mRNA.

Results: Cells overexpressing Bcl-2 survived approximately 20% more than control cells when exposed to H(2)O(2) and approximately 35% proteins were protected from oxidation, but Bcl-2 did not slow proliferation or induced senescence. Bcl-2 overexpression did not change alpha-SMA levels, but it increased TIMP-1 (55%), tissue transglutaminases (tTG) (25%) and TGF-beta mRNA (49%), when exposed to acetaldehyde, while MMP-13 content decreased (47%).

Conclusions: Bcl-2 overexpression protected HSC against oxidative stress but it did not induce replicative senescence. It increased TIMP-1, tTG and TGF-beta mRNA levels and decreased MMP-13 content, suggesting that Bcl-2 overexpression may play a key role in the progression of fibrosis in chronic liver diseases.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetaldehyde / pharmacology
  • Actins / metabolism
  • Animals
  • Cell Line
  • Cell Proliferation
  • Cellular Senescence
  • DNA Replication
  • Dose-Response Relationship, Drug
  • Extracellular Matrix / metabolism
  • GTP-Binding Proteins / metabolism
  • Hepatic Stellate Cells / drug effects
  • Hepatic Stellate Cells / metabolism*
  • Hepatic Stellate Cells / pathology
  • Humans
  • Hydrogen Peroxide / pharmacology
  • Liver Cirrhosis / genetics
  • Liver Cirrhosis / metabolism*
  • Liver Cirrhosis / pathology
  • Matrix Metalloproteinase 13 / metabolism
  • Oxidants / pharmacology
  • Oxidative Stress
  • Protein Glutamine gamma Glutamyltransferase 2
  • Proto-Oncogene Proteins c-bcl-2 / genetics
  • Proto-Oncogene Proteins c-bcl-2 / metabolism*
  • RNA, Messenger / metabolism
  • Rats
  • Recombinant Fusion Proteins / metabolism
  • Time Factors
  • Tissue Inhibitor of Metalloproteinase-1 / metabolism
  • Transfection
  • Transforming Growth Factor beta / genetics
  • Transglutaminases / metabolism
  • Up-Regulation

Substances

  • Actins
  • Oxidants
  • Proto-Oncogene Proteins c-bcl-2
  • RNA, Messenger
  • Recombinant Fusion Proteins
  • Tissue Inhibitor of Metalloproteinase-1
  • Transforming Growth Factor beta
  • smooth muscle actin, rat
  • Hydrogen Peroxide
  • Protein Glutamine gamma Glutamyltransferase 2
  • Transglutaminases
  • Matrix Metalloproteinase 13
  • Mmp13 protein, rat
  • GTP-Binding Proteins
  • Acetaldehyde